In this study, we evaluated the fully automated ready-to-use IdyllaTM PCR-based system for identification of BRAF V600 and NRAS mutations in plasma samples from patients with metastatic melanoma at baseline and during the course of treatment. Here, BRAF is linked to metastatic melanoma.